Drug profile · INN
obinutuzumab
GAZYVARO
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
obinutuzumab (GAZYVARO) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN obinutuzumab
Brand GAZYVARO
Route INJECTION
Formulation INJECTABLE
ATC code L01FA03
Frequently asked questions
What is obinutuzumab?
obinutuzumab (GAZYVARO) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for obinutuzumab?
GAZYVARO is a marketed brand name for obinutuzumab. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of obinutuzumab?
obinutuzumab has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.